H. Doods

Development of CGRP antagonists for the treatment of migraine.

H. Doods, 2001, Current opinion in investigational drugs.

Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment

E. Hamel, R. Abounader, M. Moreno, 2002, Neuropharmacology.

BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.

G. Schnorrenberg, K. Rudolf, H. Doods, 1999, European journal of pharmacology.

CGRP 27–37 analogues with high affinity to the CGRP1 receptor show antagonistic properties in a rat blood flow assay

B. Rist, J. Lacroix, A. Beck‐Sickinger, 1999, Regulatory Peptides.

Characterization of calcitonin gene-related peptide (CGRP) receptors and their receptor-activity-modifying proteins (RAMPs) in human brain microvascular and astroglial cells in culture

E. Hamel, J. Terrón, D. Stanimirovic, 2002, Neuropharmacology.

Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents

K. Rudolf, H. Doods, H. Wieland, 1998, British journal of pharmacology.